92 related articles for article (PubMed ID: 2148850)
1. Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.
Janssens WJ; Cools FJ; Hoskens LA; Van Nueten JM
Thromb Haemost; 1990 Aug; 64(1):91-6. PubMed ID: 2148850
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
Bourgain RH; Andries R; Decuyper K; De Clerck F
J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
Park SJ; Lee JJ; Vanhoutte PM
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):872-8. PubMed ID: 11270983
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
De Clerck F; Loots W; Somers Y; Beetens J; Wouters L; Wynants J; Janssen PA
Br J Pharmacol; 1990 Apr; 99(4):631-6. PubMed ID: 2113823
[TBL] [Abstract][Full Text] [Related]
7. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
8. Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivo.
Watts IS; White BP; Wharton KA; Lumley P
Br J Pharmacol; 1989 Dec; 98 Suppl():842P. PubMed ID: 2611538
[No Abstract] [Full Text] [Related]
9. Antagonism of thromboxane receptor induced contractions in isolated human groin lymphatics.
Sjöberg T; Andersson KE; Norgren L; Steen S
Lymphology; 1989 Sep; 22(3):135-40. PubMed ID: 2532276
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
11. Different sensitivity of basilar and saphenous arteries to thromboxane A2-induced contractions. Effect of imidazole 2-hydroxybenzoate (ITF 182).
Pagella PG; Agozzino S; Bellavite O; Donà GC; Mendola N
Arzneimittelforschung; 1984; 34(11):1514-6. PubMed ID: 6596952
[TBL] [Abstract][Full Text] [Related]
12. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
13. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
[TBL] [Abstract][Full Text] [Related]
14. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
15. BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractions.
Janssens WJ; Deckmyn H; Gresele P; Vermylen J
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):28-34. PubMed ID: 3840350
[TBL] [Abstract][Full Text] [Related]
16. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
17. Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
Svane D; Skajaa K; Andersson KE; Forman A
Obstet Gynecol; 1992 Aug; 80(2):234-40. PubMed ID: 1386150
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
19. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
20. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
